Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine

J Travel Med. 2022 Nov 4;29(7):taab169. doi: 10.1093/jtm/taab169.
No abstract available

Keywords: Miltefosine; cutaneous leishmaniasis; diabetes mellitus; liposomal amphotericin B; post-kala-azar dermal leishmaniasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiprotozoal Agents* / therapeutic use
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Leishmania infantum*
  • Leishmaniasis, Cutaneous* / diagnosis
  • Leishmaniasis, Cutaneous* / drug therapy
  • Leishmaniasis, Visceral* / diagnosis
  • Leishmaniasis, Visceral* / drug therapy
  • Phosphorylcholine / therapeutic use

Substances

  • miltefosine
  • Phosphorylcholine
  • Antiprotozoal Agents